http://www.guerrillanews.com/forum/thread.php?id=1284
Can't remember where I got this from but it's worth looking at
again...
Check out the patent at the above URL.
Attached is a section from the end of the article.
To balance the need for large numbers of silver ions with the need to
keep the amount of silver within safer ranges for humans, the power
supply 110 supplies two and one-half microamps of current for twelve
minutes at the beginning of treatment. This produces 1.56.times.10(13)
ions of silver per second. During the twelve minutes (i.e.,
seven-hundred twenty seconds) that the power supply 110 supplies two and
one-half microamps of current, 0.0018 Coulombs enters the bloodstream
(i.e., seven-hundred and twenty seconds multiplied by two and one-half
microamps). Under Faraday's law, one mole of silver ions equals 96485
Coulombs. Further, one mole of silver ions weighs 107.87 grams. Thus,
in the initial twelve minute operating period, nearly two micrograms
(1.94 micrograms) of silver ions are introduced into the bloodstream.
This is less than five parts per billion silver content in the blood
serum, which is significantly below the level of harmful silver content
within a human. Thus, during the initial twelve minute treatment using
the concepts of the present invention, the silver content does not
exceed toxic levels.
After the initial twelve minute operating period, the low intensity
direct current provided by power supply 110 is reduced to one-hundred
twenty five nanoamps. This causes the production of silver ions to be
produced at a rate of seven-hundred seventy-four billion ions per
second. Under a preferred embodiment
of the present invention, this level of electric current is maintained
for a period of seventy-one hours and forty-eight minutes. During this
time (i.e., 258,480 seconds) that the power supply 110 supplies
one-hundred twenty-five nanoamps of current, 3.2.times.10(-4) Coulombs
enters the bloodstream (i.e., 258,480 seconds multiplied by one-hundred
twenty-five nanoamps). Under Faraday's
law, one mole of silver ions equals 96485 Coulombs. Further, one mole
of silver ions weighs 107.87 grams. Thus, during this entire period,
only approximately 36.1 micrograms of silver ions are introduced into
the bloodstream. Thus, in the entire seventy-two hour treatment, only
38.1 micrograms of silver have been introduced into the patient's
bloodstream. This is less than nine parts per billion silver content in
the blood serum for a seventy-two hour period, which is significantly
below the range for harmful silver content within a human.
The concepts of the present invention have been tested on subjects and
resulted in highly positive results. In a first example, the human
patient had 2,165,823 copies of the HIV virus per milliliter of blood by
the RNA PCR quantification test method. In addition, this patient's T4
cell (Helper) count was at 18. This particular subject was experiencing
serious kidney malfunction prior to
treatment. Twenty-four hours after treatment, this patient's viral
load was reduced to 1,336,817 copies of the HIV virus per milliliter of
blood while the T4 cell count was 11. Because of this patient's kidney
malfunction, it was suspected that most of the viral copies detected
during the RNA PCR quantization
test had been denatured but had not yet been removed from the patient
by the kidneys. Thus, one month after treatment, the viral load was
measured again and found to be reduced to 621,215 copies of the HIV
virus per milliliter of blood. After treatment, the patient immediately
felt improved health, was able to eat solid food, and experienced a
dramatic increase in quality of life.
A second human subject had a viral load of 1,814,466 copies of the HIV
virus per milliliter of blood (RNA PCR quantification method) and a T4
cell count of 17. This patient was too dehydrated to place the
electrode 35 into the superior vena cava. Thus, the electrode 35 was
placed in the subclavian vein. This patient was subjected to twelve
minutes of treatment at 2.5 microamps and then only forty-seven hours
and forty-eight minutes of treatment at one-hundred twenty-five
nanoamps. Forty-eight hours after treatment, the patient's viral load
and T4 cell count were measured to be 394,972 copies of the HIV virus
per milliliter of blood (RNA PCR quantization method) and 18,
respectively. Once again, this patient immediately felt improved health
and was able to eat solid food.
A third human subject had a viral load of 693,832 copies of the HIV
virus per milliliter of blood (RNA PCR quantification method) and a T4
cell count of 5. This patient was also undergoing treatment with AZT.
For this patient's treatment, the initial twelve minutes of treatment at
2.5 microamps was followed by seventy hours and eighteen minutes of
treatment at one-hundred twenty-five nanoamps. Twenty-four hours after
treatment, the patient's viral load and T4 cell count were measured to
be 634 copies of the HIV virus per milliliter of blood (RNA PCR
quantization method) and 6, respectively. Once again, this patient
immediately felt improved health, was able to eat solid food, and
experienced a dramatic increase in quality of life.
In a presently preferred method for practicing the invention, the low
intensity direct current is maintained for a longer period of time than
the seventy-two hour period discussed above. The reason for this is
that it is currently believed that it takes approximately six weeks for
an HIV virus that infects a cell to cause that cell to lyse (i.e.,
burst). Any viruses that infected a cell immediately prior to treatment
with the methods of the present invention could avoid being denatured by
a metal ion while reproducing in a T4 cell. Thus,
for a six week period following treatment, T4 cells will lyse, causing
new HIV virions to enter the bloodstream. These new HIV virions can
eventually infect new cells. Because of this, while the patient's
health may be improved in the short term, the HIV virus will once again
work to destroy the immune system in the fashion discussed above. Thus,
in a presently preferred embodiment, the patient receives an initial
treatment of 2.5 microamps for twelve minutes. Then, the low intensity
direct current is lowered to one-hundred twenty-five nanoamps for a
period of six weeks by doing this, the invention can denature the
HIV virions produced by lysing cells after treatment begins. By doing
so, virtually all of the HIV virions can be denatured, thereby resulting
in a potential cure.
The methods of this invention have also been successfully tested on a
different virus and a different host: namely, a cat infected with feline
immunodeficiency virus ("FIV"). A seven year old male house cat
weighing ten pounds and ten and three-quarter ounces had "heavy third
eyelid", some hair loss, eleven bite marks along his back and rump, and
a wound to the top of the ear, all indicative of acute disease. The cat
was anesthetized with ketamine, a catheter was placed in the neck, and
the negative electrode was placed on the underchest. Approximately four
micrograms of silver was delivered in twenty-four minutes, followed by
one-half a microgram of silver per hour for ninety minutes. The next
morning the subject cat had returned to normal activity and appetite.
Thus, method and apparatus for the treatment of blood borne viral
infections such as human immunodeficiency virus and feline
immunodeficiency virus is disclosed. While embodiments and applications
of this invention have been shown and described, it would be apparent to
those skilled in the art that many more modifications are possible
without departing from the inventive concepts herein. The invention,
therefore is not to be restricted except in accordance with the scope of
the appended claims. Furthermore, one skilled in the art will recognize
that the present invention is useful for treating infections other than
the HIV virus. For example, the teachings of the present invention
would be effective at treating patients infected with such blood-borne
pathogens as bacteria, fungi, Rickettsia, etcetera.
--
The Silver List is a moderated forum for discussing Colloidal Silver.
Instructions for unsubscribing are posted at: http://silverlist.org
To post, address your message to: [email protected]
Silver List archive: http://escribe.com/health/thesilverlist/index.html
Address Off-Topic messages to: [email protected]
OT Archive: http://escribe.com/health/silverofftopiclist/index.html
List maintainer: Mike Devour <[email protected]>
